Skip to main content
padlock icon - secure page this page is secure

Publisher: Wiley-Blackwell

Volume 88, Number 5, 1 May 2012

Immune tolerance induction in patients with severe hemophilia with inhibitors: expert panel views and recommendations for clinical practice
pp. 371-379(9)
Authors: Benson, Gary; Auerswald, Günter; Elezović, Ivo; Lambert, Thierry; Ljung, Rolf; Morfini, Massimo; Remor, Eduardo; Šalek, Silva Zupančić

Favourites:
ADD
Favourites:
ADD

Dual‐energy X‐ray absorptiometry and biochemical markers of bone turnover after autologous stem cell transplantation in myeloma
pp. 388-395(8)
Authors: Laroche, Michel; Lemaire, Olivia; Bourin, Philippe; Corre, Jill; Gadelorge, Mélanie; Roussel, Muriel; Attal, Michel

Favourites:
ADD

Hypoxia improves expansion potential of human cord blood–derived hematopoietic stem cells and marrow repopulation efficiency
pp. 396-405(10)
Authors: Roy, Sushmita; Tripathy, Manjul; Mathur, Nitin; Jain, Asish; Mukhopadhyay, Asok

Favourites:
ADD

The novel, orally bioavailable HSP90 inhibitor NVP‐HSP990 induces cell cycle arrest and apoptosis in multiple myeloma cells and acts synergistically with melphalan by increased cleavage of caspases
pp. 406-415(10)
Authors: Lamottke, Britta; Kaiser, Martin; Mieth, Maren; Heider, Ulrike; Gao, Zhenhai; Nikolova, Zariana; Jensen, Michael R.; Sterz, Jan; von Metzler, Ivana; Sezer, Orhan

Favourites:
ADD
Favourites:
ADD
Favourites:
ADD

Observational study comparing long‐term safety and efficacy of Deferasirox with Desferrioxamine therapy in chelation‐naïve children with transfusional iron overload
pp. 431-438(8)
Authors: Aydinok, Yesim; Unal, Sule; Oymak, Yesim; Vergin, Canan; Türker, Zeynep D.; Yildiz, Dilek; Yesilipek, Akif

Favourites:
ADD

Development of an ELISA method for testing VWF ristocetin cofactor activity with improved sensitivity and reliability in the diagnosis of von Willebrand disease
pp. 439-445(7)
Authors: Zhao, Yiming; Gu, Ying; Ji, Shundong; Yang, Jianfeng; Yu, Ziqian; Ruan, Changgeng

Favourites:
ADD

The potential benefits of participating in early‐phase clinical trials in multiple myeloma: long‐term remission in a patient with relapsed multiple myeloma treated with 90 cycles of lenalidomide and bortezomib
pp. 446-449(4)
Authors: Richardson, Paul G.; Laubach, Jacob P.; Schlossman, Robert L.; Ghobrial, Irene M.; Redman, Katherine C.; Mckenney, Mary; Warren, Diane; Noonan, Kimberly; Lunde, Laura; Doss, Deborah; Colson, Kathleen; Hideshima, Teru; Mitsiades, Constantine; Munshi, Nikhil C.; Anderson, Kenneth C.

Favourites:
ADD

The combination of bortezomib and dexamethasone is an efficient therapy for relapsed/refractory scleromyxedema: a rare disease with new clinical insights
pp. 450-454(5)
Authors: Cañueto, Javier; Labrador, Jorge; Román, Concepción; Santos‐Briz, Ángel; Contreras, Teresa; Gutiérrez, Norma Carmen; García‐Sanz, Ramón

Favourites:
ADD

Absence of DNMT3A gene mutation in chronic myeloid leukemia patients in blast crisis
pp. 455-457(3)
Authors: Li, Xianmin; Cen, Jiannong; Wang, Qinrong; Dong, Shasha; Wu, Lili; Ping, Nana; Ding, Zixuan; Wu, Depei; Chen, Zixing; Chen, Suning

Favourites:
ADD

Hemophagocytic syndrome after allogeneic hematopoietic cell transplantation: more a graft rejection than an infectious process?
pp. 458-460(3)
Authors: Redjoul, Rabah; Toma, Andréa; Hicheri, Yosr; Maaroufi, Hicham El; Maertens, Johan; Vigouroux, Stéphane; Lioure, Bruno; Machaczka, Maciej; Pautas, Cécile; Bories, Dominique; Wagner‐Ballon, Orianne; Gaulard, Philippe; Martin‐Garcia, Nadine; Maury, Sébastien; Cordonnier, Catherine

Favourites:
ADD

Major plasma cells’ dystrophy in monoclonal gammopathy of undeterminated significance
pp. 461-461(1)
Authors: Klein, E.; Ronez, E.; Drouet, L.

Favourites:
ADD
Favourites:
ADD

Lymphoma and Leukemia of the Nervous System
pp. 463-463(1)
Author: Coiffier, Bertrand

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more